Dr Reddy’s Laboratories among top 15 biotech and pharma employers in Science Magazine Survey Read more
Lilly’s donanemab could bring new hope to Alzheimer’s patients in Australia following lecanemab rejection: GlobalData Read more
NICE rejects second Alzheimer’s drug but opportunity remains for decision change: GlobalData Read more